Derya Özden Omaygenç
Research Subjects
Derya Özden Omaygenç has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Ipek Saadet Edipoglu
Department of Anaesthesia, University Hospital Lewisham, London, UK
2 shared publications Oznur Sen
Department of Anesthesiology, Istanbul Haseki Training and Research Hospital, Istanbul, Turkey
2 shared publications- Ziya Salihoglu
Department of Anesthesiology & Reanimation, Faculty of Medicine, University of Istanbul-Cerrahpasa, Istanbul, Turkey
2 shared publications - Abdulhakim Şengel
Harran University
1 shared publication - Adnan Sayar
Sisli Mem Hosp, Dept Thorac Surg, Istanbul, Turkey
1 shared publication - Ahmet Adiguzel
14Department of Neurology, Faculty of Medicine, İnönü University, Malatya, Turkiye
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Egyptian Knowledge Bank in Ain-Shams Journal of Anesthesiology
- Vol. 17 (1) , 1-8
Airway complications associated with laryngeal mask use in short surgical procedures – A training perspective.
Background: Laryngeal masks (LMA) are frequently used as primary airway devices for anesthetic management of short procedures. A steep learning curve for insertion and low major complication rates are the main advantages of these devices. However, minor events associated with their mass effect are not rare. The impact of the operator's experience on this subject is also undetermined. Here, we aimed to assess the predictors of complication occurrence in the hands of anesthesiology residents who provided perioperative management for all cases.Results: Seventy-five ASA I-II patients were enrolled. The appropriate sizes of LMA Proseal ™ or LMA Fastrach ™ were utilized for establishing airway patency. The sample population was grouped according to the occurrence of at least one pre-specified complication (Groups C and NC). Twenty-five events were observed in 20 (26.7%) patients. Demographic features were comparable between groups. There were no significant differences in terms of the preferred LMA, operator experience, or ventilator-related parameters between individuals with and without complications. Among the complete set of data, the additional need for anesthesia was the only variable independently associated with outcome (OR: 0.19; p = 0.01).Conclusion: In our population, comprising patients undergoing a brief urological procedure under general anesthesia, the only determinant of complication occurrence was the additional need for propofol during the procedure. The choice of the LMA and the experience of the resident were not associated with the composite endpoint.
- 1 January 2025
- Published by Egyptian Knowledge Bank in Ain-Shams Journal of Anesthesiology
- Vol. 17 (1) , 1-8
Open AccessAirway complications associated with laryngeal mask use in short surgical procedures – A training perspective.
Background: Laryngeal masks (LMA) are frequently used as primary airway devices for anesthetic management of short procedures. A steep learning curve for insertion and low major complication rates are the main advantages of these devices. However, minor events associated with their mass effect are not rare. The impact of the operator's experience on this subject is also undetermined. Here, we aimed to assess the predictors of complication occurrence in the hands of anesthesiology residents who provided perioperative management for all cases.Results: Seventy-five ASA I-II patients were enrolled. The appropriate sizes of LMA Proseal ™ or LMA Fastrach ™ were utilized for establishing airway patency. The sample population was grouped according to the occurrence of at least one pre-specified complication (Groups C and NC). Twenty-five events were observed in 20 (26.7%) patients. Demographic features were comparable between groups. There were no significant differences in terms of the preferred LMA, operator experience, or ventilator-related parameters between individuals with and without complications. Among the complete set of data, the additional need for anesthesia was the only variable independently associated with outcome (OR: 0.19; p = 0.01).Conclusion: In our population, comprising patients undergoing a brief urological procedure under general anesthesia, the only determinant of complication occurrence was the additional need for propofol during the procedure. The choice of the LMA and the experience of the resident were not associated with the composite endpoint.
- 13 February 2023
- Vol. 94 (1) , e2023007
Baseline serum vitamin A and vitamin C levels and their association with disease severity in COVID-19 patients.
We aimed to investigate the association between the serum concentrations of Vitamin A and Vitamin C and the severity of the COVID-19. Methods: Fifty-three consecutive PCR (+) COVID-19 patients admitted to a dedicated ward were enrolled in this study. Blood samples for serum Vitamin A and C measurements were drawn from all participants upon admission. All subjects underwent thoracic CT imaging prior to hospitalization. CT severity score (CT-SS) was then calculated for determining the extent of pulmonary involvement. A group of healthy volunteers, in whom COVID-19 was ruled out, were assigned to the control group (n=26). These groups were compared by demographic features and serum vitamin A and C levels. The relationship between serum concentrations of these vitamins and pre-defined outcome measures, CT-SS and length of hospitalization (LOH), was also assessed. Results: In COVID-19 patients, serum Vitamin A (ng/ml, 494±96 vs. 698±93; p<0.001) and Vitamin C (ng/ml, 2961 [1991-31718] vs. 3953 [1385-8779]; p=0.007) levels were significantly lower with respect to healthy controls. According to the results of correlation analyses, there was a significant negative association between Vitamin A level and outcome measures (LOH, r=-0.293; p=0.009 and CT-SS, r=-0.289; p=0.010). The negative correlations between Vitamin C level and those measures were even more prominent (LOH, r=-0.478; p<0.001 and CT-SS, r=-0.734: p<0.001). COVID-19 patients had lower baseline serum Vitamin A and Vitamin C levels as compared to healthy controls. In subjects with COVID-19, Vitamin A and Vitamin C levels were negatively correlated with CT-SS and LOH.
- 13 February 2023
- Vol. 94 (1) , e2023007
Baseline serum vitamin A and vitamin C levels and their association with disease severity in COVID-19 patients.
We aimed to investigate the association between the serum concentrations of Vitamin A and Vitamin C and the severity of the COVID-19. Methods: Fifty-three consecutive PCR (+) COVID-19 patients admitted to a dedicated ward were enrolled in this study. Blood samples for serum Vitamin A and C measurements were drawn from all participants upon admission. All subjects underwent thoracic CT imaging prior to hospitalization. CT severity score (CT-SS) was then calculated for determining the extent of pulmonary involvement. A group of healthy volunteers, in whom COVID-19 was ruled out, were assigned to the control group (n=26). These groups were compared by demographic features and serum vitamin A and C levels. The relationship between serum concentrations of these vitamins and pre-defined outcome measures, CT-SS and length of hospitalization (LOH), was also assessed. Results: In COVID-19 patients, serum Vitamin A (ng/ml, 494±96 vs. 698±93; p<0.001) and Vitamin C (ng/ml, 2961 [1991-31718] vs. 3953 [1385-8779]; p=0.007) levels were significantly lower with respect to healthy controls. According to the results of correlation analyses, there was a significant negative association between Vitamin A level and outcome measures (LOH, r=-0.293; p=0.009 and CT-SS, r=-0.289; p=0.010). The negative correlations between Vitamin C level and those measures were even more prominent (LOH, r=-0.478; p<0.001 and CT-SS, r=-0.734: p<0.001). COVID-19 patients had lower baseline serum Vitamin A and Vitamin C levels as compared to healthy controls. In subjects with COVID-19, Vitamin A and Vitamin C levels were negatively correlated with CT-SS and LOH.
- Open Access
- 1 January 2023
- Published by Kare Publishing in Haydarpasa Numune Training and Research Hospital Medical Journal
- Vol. 64 (2) , 218-225
Acute kidney injury after hip replacement surgery under spinal anesthesia in the elderly: A retrospective analysis
- 1 January 2023
- Published by Kare Publishing in Haydarpasa Numune Training and Research Hospital Medical Journal
- Vol. 64 (2) , 218-225
Open AccessAcute kidney injury after hip replacement surgery under spinal anesthesia in the elderly: A retrospective analysis
- 6 December 2022
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 31 (1)
An Unfrequent Neurologic Complication of COVID-19 at the Critical Care Unit
- 6 December 2022
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 31 (1)
An Unfrequent Neurologic Complication of COVID-19 at the Critical Care Unit
- 21 April 2022
- Published by Academician Publishing
- p. 239-276
Akut Respiratuar Distres Sendromunda Kişiselleştirilmiş Tıbba Doğru
Akut Respiratuar Distres Sendromu (ARDS), yüksek mortalite oranına sahip, etiyolojik ve biyokimyasal açıdan heterojen bir kritik hastalıktır. Geleneksel tedavilerin yetersiz kalması, hastalığın alt fenotiplerinin doğru tanımlanmasını ve kişiselleştirilmiş tıp yaklaşımlarını zorunlu kılmıştır. ARDS, Berlin tanımlamasına göre hipoksemi ciddiyetine göre sınıflandırılsa da, bu durum her zaman klinik sonlanımlarla doğrudan ilişkili değildir. Patofizyolojik olarak alveolo-kapiller membran hasarı ve enflamasyonla karakterize olan hastalıkta, erken dönemde yaygın alveolar hasar, geç dönemde ise bazı hastalarda fibroproliferasyon gözlenir. Klinik çalışmalarda genel yaklaşımların %95'inin başarısız olması, "heterojen tedavi etkisi" kavramını ön plana çıkarmıştır. Latent Sınıf Analizi gibi yöntemlerle "hiperenflamatuar" ve "hipoenflamatuar" gibi biyolojik subfenotipler tanımlanmış, bu grupların PEEP stratejilerine ve sıvı tedavilerine farklı yanıtlar verdiği saptanmıştır. Günümüzde akciğer koruyucu ventilasyon ve yüzüstü pozisyonlama temel tedavi stratejileridir. Kişiselleştirilmiş tıp kapsamında omik analizleri, biyobelirteçler (Ang-2, sRAGE, IL-8 vb.) ve yapay zeka entegrasyonu, doğru hastaya doğru zamanda müdahale edilmesini hedeflemektedir. Gelecekte, genetik ve moleküler düzeydeki bu verilerin yatak başı uygulamalara dönüştürülmesiyle ARDS prognozunda anlamlı iyileşmeler beklenmektedir. Acute Respiratory Distress Syndrome (ARDS) is a critical condition characterized by high mortality and significant heterogeneity in its etiological and biochemical presentation. The failure of traditional, one-size-fits-all treatments has highlighted the necessity for identifying specific subphenotypes and adopting personalized medicine approaches. While ARDS is classified by the severity of hypoxemia according to the Berlin Definition, this classification does not always correlate directly with clinical outcomes. Pathophysiological features include alveolar-capillary membrane damage and inflammation, leading to diffuse alveolar damage in the acute phase and potential fibroproliferation in later stages. The 95% failure rate of general clinical trials underscores the "heterogeneity of treatment effect". Advanced methods like Latent Class Analysis have identified "hyperinflammatory" and "hypoinflammatory" biological subphenotypes, which respond differently to PEEP strategies and fluid management. Currently, lung-protective ventilation and prone positioning remain the cornerstones of treatment. Personalized medicine aims to leverage omics analysis, biomarkers (such as Ang-2, sRAGE, and IL-8), and AI integration to provide targeted interventions. The future of ARDS management lies in translating these genetic and molecular insights into bedside applications to improve patient prognosis.
- 21 April 2022
- Published by Academician Publishing
- p. 239-276
Akut Respiratuar Distres Sendromunda Kişiselleştirilmiş Tıbba Doğru
Akut Respiratuar Distres Sendromu (ARDS), yüksek mortalite oranına sahip, etiyolojik ve biyokimyasal açıdan heterojen bir kritik hastalıktır. Geleneksel tedavilerin yetersiz kalması, hastalığın alt fenotiplerinin doğru tanımlanmasını ve kişiselleştirilmiş tıp yaklaşımlarını zorunlu kılmıştır. ARDS, Berlin tanımlamasına göre hipoksemi ciddiyetine göre sınıflandırılsa da, bu durum her zaman klinik sonlanımlarla doğrudan ilişkili değildir. Patofizyolojik olarak alveolo-kapiller membran hasarı ve enflamasyonla karakterize olan hastalıkta, erken dönemde yaygın alveolar hasar, geç dönemde ise bazı hastalarda fibroproliferasyon gözlenir. Klinik çalışmalarda genel yaklaşımların %95'inin başarısız olması, "heterojen tedavi etkisi" kavramını ön plana çıkarmıştır. Latent Sınıf Analizi gibi yöntemlerle "hiperenflamatuar" ve "hipoenflamatuar" gibi biyolojik subfenotipler tanımlanmış, bu grupların PEEP stratejilerine ve sıvı tedavilerine farklı yanıtlar verdiği saptanmıştır. Günümüzde akciğer koruyucu ventilasyon ve yüzüstü pozisyonlama temel tedavi stratejileridir. Kişiselleştirilmiş tıp kapsamında omik analizleri, biyobelirteçler (Ang-2, sRAGE, IL-8 vb.) ve yapay zeka entegrasyonu, doğru hastaya doğru zamanda müdahale edilmesini hedeflemektedir. Gelecekte, genetik ve moleküler düzeydeki bu verilerin yatak başı uygulamalara dönüştürülmesiyle ARDS prognozunda anlamlı iyileşmeler beklenmektedir. Acute Respiratory Distress Syndrome (ARDS) is a critical condition characterized by high mortality and significant heterogeneity in its etiological and biochemical presentation. The failure of traditional, one-size-fits-all treatments has highlighted the necessity for identifying specific subphenotypes and adopting personalized medicine approaches. While ARDS is classified by the severity of hypoxemia according to the Berlin Definition, this classification does not always correlate directly with clinical outcomes. Pathophysiological features include alveolar-capillary membrane damage and inflammation, leading to diffuse alveolar damage in the acute phase and potential fibroproliferation in later stages. The 95% failure rate of general clinical trials underscores the "heterogeneity of treatment effect". Advanced methods like Latent Class Analysis have identified "hyperinflammatory" and "hypoinflammatory" biological subphenotypes, which respond differently to PEEP strategies and fluid management. Currently, lung-protective ventilation and prone positioning remain the cornerstones of treatment. Personalized medicine aims to leverage omics analysis, biomarkers (such as Ang-2, sRAGE, and IL-8), and AI integration to provide targeted interventions. The future of ARDS management lies in translating these genetic and molecular insights into bedside applications to improve patient prognosis.
- Open Access
- 21 April 2022
- Published by Academician Publishing
Anestezide İnovatif Teknolojiler
Yeniliklerin yayılması kuramı; yeni fikirlerin, yaşam tarzlarının ve teknolojilerin nasıl yayıldığını açıklamaya çalışan bir kuramdır. Kuram belli bir zaman serisi üzerinden insanları yenilikler ile kurduğu ilişki içerisinde yenilikleri benimseme kriterine göre sınıflandırmaktadır. Everett Rogers’ın 1962 yılında ‘Yeniliklerin Yayılımı’ (Diffusion of Innovation) başlıklı çalışmayı yayınlaması ile akademik hayata girmiştir. Yeniliğin yayılması bir süreçtir. İçinde bulunduğumuz COVID-19 Pandemisi, getirdiği pek çok zorluğun ve acının yanı sıra birçok yeniliğin yayılımını ve kullanım sürecini de arttırmıştır. Bu disiplinler içerisinde Anesteziyoloji ve Reanimasyon Bilim Dalı önemini korumaktadır. Anestezi hekimlerinin “Yoğun Bakım Bilimi” ile özdeşleştiği ve pandeminin bu bilim dalının önemini vurguladığı bu günlerde, Anestezi ve Yoğun Bakım alanındaki inovatif teknolojileri ve kullanım alanlarını irdelemek istedim.
- 21 April 2022
- Published by Academician Publishing
Open AccessAnestezide İnovatif Teknolojiler
Yeniliklerin yayılması kuramı; yeni fikirlerin, yaşam tarzlarının ve teknolojilerin nasıl yayıldığını açıklamaya çalışan bir kuramdır. Kuram belli bir zaman serisi üzerinden insanları yenilikler ile kurduğu ilişki içerisinde yenilikleri benimseme kriterine göre sınıflandırmaktadır. Everett Rogers’ın 1962 yılında ‘Yeniliklerin Yayılımı’ (Diffusion of Innovation) başlıklı çalışmayı yayınlaması ile akademik hayata girmiştir. Yeniliğin yayılması bir süreçtir. İçinde bulunduğumuz COVID-19 Pandemisi, getirdiği pek çok zorluğun ve acının yanı sıra birçok yeniliğin yayılımını ve kullanım sürecini de arttırmıştır. Bu disiplinler içerisinde Anesteziyoloji ve Reanimasyon Bilim Dalı önemini korumaktadır. Anestezi hekimlerinin “Yoğun Bakım Bilimi” ile özdeşleştiği ve pandeminin bu bilim dalının önemini vurguladığı bu günlerde, Anestezi ve Yoğun Bakım alanındaki inovatif teknolojileri ve kullanım alanlarını irdelemek istedim.
- 11 April 2022
- Published by Academician Publishing
- p. 201-224
Akut Respiratuar Distres Sendromunda Kişiselleştirilmiş Tıbba Doğru
Akut Respiratuar Distres Sendromu (ARDS), akciğerlerde yaygın enflamasyon ve ödemle seyreden, yüksek mortalite oranına sahip oldukça heterojen bir kritik hastalıktır. Mevcut tedavi yaklaşımları tüm hastalar için standart bir protokol sunsa da, hastalığın klinik ve biyolojik çeşitliliği nedeniyle kişiselleştirilmiş tıp ve subfenotipleme yöntemleri ön plana çıkmaktadır. Yapılan çalışmalar, hastaların hiperenflamatuar ve hipoenflamatuar gibi farklı biyolojik alt gruplara ayrıldığını ve bu grupların PEEP stratejileri ile sıvı tedavilerine farklı yanıtlar verdiğini göstermektedir. Gelecekte -omik teknolojileri ve yapay zeka destekli analizlerin entegrasyonuyla, her hastanın spesifik biyolojik profiline uygun daha etkin tedavi modellerinin geliştirilmesi hedeflenmektedir. Acute Respiratory Distress Syndrome (ARDS) is a highly heterogeneous critical illness characterized by widespread pulmonary inflammation and edema, maintaining high mortality rates. While current treatments follow a standardized protocol, the clinical and biological diversity of the disease emphasizes the need for personalized medicine and subphenotyping. Research indicates that patients fall into distinct biological subgroups, such as hyperinflammatory and hypoinflammatory, which respond differently to PEEP strategies and fluid management. Future goals involve integrating -omic technologies and AI-driven analyses to develop more effective treatment models tailored to each patient's specific biological profile.
- 11 April 2022
- Published by Academician Publishing
- p. 201-224
Akut Respiratuar Distres Sendromunda Kişiselleştirilmiş Tıbba Doğru
Akut Respiratuar Distres Sendromu (ARDS), akciğerlerde yaygın enflamasyon ve ödemle seyreden, yüksek mortalite oranına sahip oldukça heterojen bir kritik hastalıktır. Mevcut tedavi yaklaşımları tüm hastalar için standart bir protokol sunsa da, hastalığın klinik ve biyolojik çeşitliliği nedeniyle kişiselleştirilmiş tıp ve subfenotipleme yöntemleri ön plana çıkmaktadır. Yapılan çalışmalar, hastaların hiperenflamatuar ve hipoenflamatuar gibi farklı biyolojik alt gruplara ayrıldığını ve bu grupların PEEP stratejileri ile sıvı tedavilerine farklı yanıtlar verdiğini göstermektedir. Gelecekte -omik teknolojileri ve yapay zeka destekli analizlerin entegrasyonuyla, her hastanın spesifik biyolojik profiline uygun daha etkin tedavi modellerinin geliştirilmesi hedeflenmektedir. Acute Respiratory Distress Syndrome (ARDS) is a highly heterogeneous critical illness characterized by widespread pulmonary inflammation and edema, maintaining high mortality rates. While current treatments follow a standardized protocol, the clinical and biological diversity of the disease emphasizes the need for personalized medicine and subphenotyping. Research indicates that patients fall into distinct biological subgroups, such as hyperinflammatory and hypoinflammatory, which respond differently to PEEP strategies and fluid management. Future goals involve integrating -omic technologies and AI-driven analyses to develop more effective treatment models tailored to each patient's specific biological profile.
- 1 January 2022
- Published by Care Comm in Česká gynekologie
- Vol. 87 (4) , 232-238
Comparison of enhanced recovery protocol with conventional care in patients undergoing urogynecological surgery
: Objective: The impact of enhanced recovery after surgery (ERAS) protocol on postoperative outcomes after urogynecological surgery is yet to be a matter of investigation. This study sought to evaluate this issue by comparing the patients who had conventional or ERAS--guidedperioperative care for several clinical end-points including ambulation, length of hospital stay (LOS), readmissions, and postoperative complications.Materials and methods: A total of 121 patients undergoing pelvic organ prolapse surgery were allocated to two study arms, ERAS protocol (Group E) or conventional care (Group C). Variables reflecting the restoration of appetite and bowel movements, bleeding events, other complications, LOS and readmissions were compared between the groups.Results: The patients in Group C signifi cantly received a more intensive intravenous fluid treatment compared to Group E (2,760 +/- 656 vs. 1,045 +/- 218 mL, P < 0.001). Time required for first flatus, first defecation, eating solid food, and ambulation (P < 0.001) were also longer in the former group of patients. Moreover, LOS was significantly reduced when the ERAS protocol was applied (2.5 +/- 1.1 vs. 2.0 +/- 0.6 days, P < 0.001). On the other hand, the two groups were similar with respect to the frequency of the postoperative complications, including surgical site infections, cardiovascular complications, non-specific abdominal pain, sub-ileus, blood loss and readmission rate. Conclusion: In our sample population, ERAS protocol led to early initiation of oral intake, early recovery of bowel function, early mobilization, and early discharge of patients without compromise in safety concerns after urogynecological surgery.
- 1 January 2022
- Published by Care Comm in Česká gynekologie
- Vol. 87 (4) , 232-238
Comparison of enhanced recovery protocol with conventional care in patients undergoing urogynecological surgery
: Objective: The impact of enhanced recovery after surgery (ERAS) protocol on postoperative outcomes after urogynecological surgery is yet to be a matter of investigation. This study sought to evaluate this issue by comparing the patients who had conventional or ERAS--guidedperioperative care for several clinical end-points including ambulation, length of hospital stay (LOS), readmissions, and postoperative complications.Materials and methods: A total of 121 patients undergoing pelvic organ prolapse surgery were allocated to two study arms, ERAS protocol (Group E) or conventional care (Group C). Variables reflecting the restoration of appetite and bowel movements, bleeding events, other complications, LOS and readmissions were compared between the groups.Results: The patients in Group C signifi cantly received a more intensive intravenous fluid treatment compared to Group E (2,760 +/- 656 vs. 1,045 +/- 218 mL, P < 0.001). Time required for first flatus, first defecation, eating solid food, and ambulation (P < 0.001) were also longer in the former group of patients. Moreover, LOS was significantly reduced when the ERAS protocol was applied (2.5 +/- 1.1 vs. 2.0 +/- 0.6 days, P < 0.001). On the other hand, the two groups were similar with respect to the frequency of the postoperative complications, including surgical site infections, cardiovascular complications, non-specific abdominal pain, sub-ileus, blood loss and readmission rate. Conclusion: In our sample population, ERAS protocol led to early initiation of oral intake, early recovery of bowel function, early mobilization, and early discharge of patients without compromise in safety concerns after urogynecological surgery.
- Open Access
- 21 June 2021
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 49 (3) , 224-229
Anaesthesia-Related Internet Search: A Survey with Turkish Participants
Anaesthesia,Internet,online systems,pre-operative period
- 21 June 2021
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 49 (3) , 224-229
Open AccessAnaesthesia-Related Internet Search: A Survey with Turkish Participants
Anaesthesia,Internet,online systems,pre-operative period